AI Protein Design Market Size to Hit USD 39.58 Billion by 2034 | 35.28% CAGR

The global AI protein design market size was valued at USD 1.86 billion in 2025 and is expected to reach USD 39.58 billion by 2034, growing at a CAGR of 35.28% during 2026–2034, according to a new study by Polaris Market Research. The report, “AI Protein Design Market Size, Share, Trends, & Industry Analysis Report By Design Approach, By Protein Modality, By Application, By End User, and By Region – Market Forecast, 2026–2034” examines demand patterns, pipeline momentum, shifts in design technology, deal-making activity, and growth prospects across major regions.

AI is turning protein discovery from a slow, trial-and-error exercise into a data-driven one, where candidate molecules are scored on a computer long before any bench work begins. Design platforms can now propose entirely new proteins, rework existing ones, and rank the results by predicted performance. Drug developers, enzyme makers, and university labs are all adopting these tools to reach a usable lead faster and with fewer failed experiments.

Therapeutics is where commercial momentum is strongest, with AI-designed antibodies now moving from computer screens into human trials. The most advanced candidates have reached late-stage testing, and several specialist platform companies have attracted multi-program deals from large drugmakers. Together, these developments are shifting AI protein design from a research aid into a revenue-generating part of biologics R&D.

“Buyers used to ask whether AI could design a protein that works in a lab test. The question now is whether it can shorten the road to the clinic in a way that shows up in a program budget, and that is a much harder bar to clear. In my view, the whole category will be judged on the first few late-stage readouts, not just the companies behind them. A clean result would pull pharma money toward design platforms quickly. A disappointing one would make partners slow down and ask for more proof before they sign. Over the next two to three years, I would watch clinical data more closely than any new model release,” said Prajakta Bengale, Research Manager, Polaris Market Research.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: AI Protein Design Market Report

AI Protein Design Market Report Highlights

• Antibodies led the protein modality segment with a 31.46% share in 2025, as developers favor a format with a long record of regulatory success.

• Generative de novo design is the fastest-growing design approach, projected to expand at a 40.42% CAGR during 2026–2034 as teams build binders and miniproteins from scratch for hard-to-reach targets.

• Therapeutics led the application segment in 2025, as biologics developers use AI to cut early-stage attrition.

• Pharmaceutical & biotechnology companies remained the largest end user group, investing in design capabilities to strengthen their biologics pipelines.

• North America held the largest regional share in 2025, backed by deep venture funding, a large base of platform developers, and close links between AI labs and biotech hubs.

• Asia Pacific is expected to be the fastest-growing region, advancing at a 39.46% CAGR during 2026–2034 as biotech funding rises and design tools become easier to access.

• Europe remains a steady contributor, supported by its pharmaceutical base and computational biology expertise.

• Major players include Generate Biomedicines, Absci, Xaira Therapeutics, EvolutionaryScale, Profluent, Cradle, Latent Labs, and Chai Discovery.

AI Protein Design Market  report based on design approach, protein modality, application, end user, and region:

By Design Approach Outlook (Revenue, USD Billion, 2021–2034)

• Structure Prediction
• Generative De Novo Design
• AI Guided Sequence Optimization

By Protein Modality Outlook (Revenue, USD Billion, 2021–2034)

• Antibodies
• De Novo Binders & Miniproteins
• Enzymes
• Peptides
• Others

By Application Outlook (Revenue, USD Billion, 2021–2034)

• Therapeutics
• Industrial & Enzyme Applications
• Research

By End User Outlook (Revenue, USD Billion, 2021–2034)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes

• Contract Research Organizations

By Regional Outlook (Revenue, USD Billion, 2021–2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa